Dutasteride Tablets 0.5 mg (Dutasteride)

Adult dose

The recommended dose of this medicine is 1 tablet (0.5mg) once daily. Swallow this medicine whole without chewing or splitting it. This medicine may be taken with or without food. No dose adjustment is necessary for patients with renal impairment or elderly patients. The recommended dose of this medicine in patients with hepatic impairment has not been established because there are no data on its administration to such patients.

This medication can be absorbed through the skin, so women who are pregnant or may become pregnant should avoid direct contact or handling of this medication. Particularly, care should be taken to avoid touching broken or crushed tablets. Children under 18 years of age should also avoid contact with this medication, and it should not be administered to them as safety and efficacy have not been established. This medication should not be given to women or children under 18, and those allergic to this medication or similar substances should not use it. Adult men planning to conceive should use this medication carefully after consulting a physician, as it may affect fertility. This medication may not be suitable for patients with difficult urinary discharge or severe urinary retention, and such cases should be monitored closely for urinary obstruction. Patients with liver dysfunction should be cautious, as the metabolism of this medication may be affected. When taken with strong CYP3A4 enzyme inhibitors, the blood concentration of this medication may increase, so caution is advised when used together. While using this medication, erectile dysfunction, decreased libido, and ejaculation disorders may occur as adverse reactions related to sexual function, and these symptoms may persist after discontinuation of the medication. In addition, breast-related adverse reactions such as gynecomastia, breast tenderness, and breast enlargement have been reported. This medication decreases PSA levels, which are important for assessing the risk of prostate cancer, so PSA results should be interpreted considering levels before and after taking the medication, and regular prostate cancer screenings are recommended. Patients taking this medication should not donate blood for at least six months after the last dose to prevent this medication from being administered to pregnant women. In case of overdose, there is no specific antidote, and appropriate supportive treatment should be provided according to symptoms, noting that this medication has a long half-life. Store it out of reach of children and in its original container to prevent misuse or quality degradation. This medication is unlikely to affect the ability to drive or operate machinery, but caution is advised in patients with heart failure. Finally, this medication must not be used by pregnant women or nursing mothers, and elderly patients or those with certain diseases should take it cautiously under medical supervision.

• Erectile dysfunction
• decreased libido
• ejaculation disorders
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorders
• dizziness
• rash

This medication should be stored in a tightly closed container to prevent air ingress, preferably at room temperature between 1 and 30 degrees Celsius. This helps maintain the medication's effectiveness and prevent degradation.

Appearance

Pale yellow oval film-coated tablet

Package unit

30 tablets/PTP [10 tablets/PTP x 3]